SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
SocialPicks Community
Epinex Diagnostics: A New Paradigm for Diabetic Testing
JNJ
|
|
|
+2.95%
in
17 days
Epinex Diagnostics Inc. (click on preceding link for the Company's News Room page) is a private company that is dedicated to the development of innovative point-of-care technologies using rapid diagnostic tests. Epinex has developed a proprietary platform for rapid tests that apply existing immunoassay strips and biosensors to create unique quantitative diagnostic tests. Advantages of the Epinex Quantitative Immunoassay System for Point-of-Care Testing include the following: 1.) Rapid: Results within minutes. <> 2.) Quantitative: Yields a<><><><><><><>< /><><>< /><><><><><><><>< /><>< /><><><><><><><><><>...
|
JNJ undervalued
JNJ
|
|
|
+6.54%
in
135 days
JNJ is a market leading company that Warren Buffett acknowledges has a competitive advantage. I have analysed the fundamentals myself on a basic level and found the company to provide satisfactory returns at the current price. Analysts are also saying that JNJ is undervalued.
|
BioMedReports: FDA Calendar Updates
JNJ
|
|
|
+5.70%
in
127 days
(closed on 11/19/09)
<> Below is a summary of updates to the BioMedReports.com FDA Calendar , which includes a database of 260 entries as of 7/15/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of BioMedReports.com , the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response letter (CRL) re-submissions to the FDA, and pending late-stage clini...
|
FDA Calendar Updates: ABII, BMRN, JNJ, OSIP, Roche
JNJ
|
|
|
+2.22%
in
2 days
(closed on 07/15/09)
<> Below is a summary of updates to the <font> BioMedReports.com FDA Calendar </font> , which includes a database of 254 entries as of 7/13/09. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of <font> BioMedReports.com </font> , the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response letter (CRL) re-submissions to the FDA, and pendin...
|
FDA, Clinical Trial Updates: Heart Stents, Cholesterol in the News
JNJ
|
|
|
+3.24%
in
54 days
(closed on 07/13/09)
<> Below is a summary of updates to the <font> BioMedReports.com </font> database of over 200 entries included in the <font> FDA and Clinical Trial Calendars </font> . The FDA Calendar includes companies with pending new drug, biological agent, or medical device new product decisions at the FDA sorted by their PDUFA decision deadline dates while the Clinical Trial Calendar encompasses pending clinical trial results (with a focus on late-stage, Phase 3 trials), pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), and pending re-submissions to the FDA fo...
|
From the Blogosphere
Top Dividend Stocks to Consider Now: Johnson & Johnson, Chevron and Merck & Co
 Sometimes you are just looking for a good dividend stock of a solid company to get your portfolio stabilized a bit. We present to you Johnson & Johnson (NYSE:JNJ), Chevron Corporation (NYSE:CVX) and Merck & Co., Inc. (NYSE:MRK).
WallStNation.com searched for dividend stocks that were yielding greater than 3%, had a payout ratio of less than 50% (to weed out companies that were paying too much and not re-investing in itself) and had a P/E ratio for the current fiscal year less than 20 (to search for some value).
read more
|
DJIA Market Wrap 5 December
|
|
|
The 60-minute trend is negative according to the force index indicator. The MACD indicator is printing a number of consecutive negative divergences. Prices are moving laterally within a trading range. The 10500 level has been tested already several times.
Almost all stocks are moving above their short, medium and long term moving averages indicating how well the trend developed. DD, MCD, TRV printed a new 20-day low. Several stocks printed new 20-day highs; they are BA, CSCO, GE, INTC, JNJ, T, VZ. INTC and JNJ printed 5 consecutive up closes.
In the Figure you can see a summary of the tren...
|
DJIA Market Wrap 5 December
The 60-minute trend is negative according to the force index indicator. The MACD indicator is printing a number of consecutive negative divergences. Prices are moving laterally within a trading range. The 10500 level has been tested already several times.
Almost all stocks are moving above their short, medium and long term moving averages indicating how well the trend developed. DD, MCD, TRV printed a new 20-day low. Several stocks printed new 20-day highs; they are BA, CSCO, GE, INTC, JNJ, T, VZ. INTC and JNJ printed 5 consecutive up closes.
In the Figure you can see a summary of the tren...
|
Baxter Gets H1N1 Vaccine Order – Analyst Blog
|
|
|
Baxter International Inc. (BAX) recently received another order for 10,000 H1N1 vaccines, commonly known as "swine flu," from Slovenia. The order is worth $158,700 (105,000 euros). It is estimated that the number of vaccines ordered is sufficient to cover 5,000 people in the country.
Slovenia has also decided to purchase a total of 1.3 million units of H1N1 vaccines from the British arm of GlaxoSmithKline plc (GSK) and the Swiss arm of Novartis AG (NVS) by the end of Jan. 2010. This would cost Slovenia roughly 14 million euros.
The new order will help Baxter boost its top-line. Baxter sees a ...
|
Favorable Outcome for Wright – Analyst Blog
|
|
|
Wright Medical Group, Inc. (WMGI) recently received a favorable summary judgment in its patent infringement case against Howmedica Osteonics Corp., a subsidiary of Stryker Corp. (SYK). The lawsuit was filed in 2000, which alleged Wright Medical’s Advance knee implant product to have violated a patent held by Howmedica. This prompted Howmedica to seek an order of infringement and unspecified damages from Wright Medical.
The U.S. District Court for the District of New Jersey invalidated Howmedica’s patent in its recent ruling on Nov 24, 2009. Stryker can file another appeal in court, faili< />< />< />< />< />< /><><><><><><><><>< />< />< /><>< /><>< /><>< /><>< /><>< /><>< /><><>< /><>< /><>< />< />...
|
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
Visit streetinsider.com
|
|
|
|
fas831
(-6.45% risk: conservative)
|
|
Johnson & Johnson vs 3M
- I have been waiting and waiting for JNJ to drop but its really dissapointing seeing such a steady stock..on the other hand is 3M who is JNJ's competito
|
More Resources
|
About Johnson & Johnson
- Answers.com
